ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2026
Quality of Online Information in Arabic for Patient Education Regarding Cancer Chemotherapy.
Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite being a significant educational resource for health-related information, the available data on the Internet lack quality control, which can lead to misconceptions and incorrect adoption of health interventions. Patients with cancer may rely on this information regarding treatment options, side effects, and precautions. This study aimed to evaluate the online Arabic content related to cancer medications, including chemotherapy, targeted therapy, and biological therapy. A search was conducted using the Google search engine with the translated Arabic keywords of "cancer medications," "cancer treatment," "targeted therapy for the treatment of cancer," "targeted therapy," "biologic therapy for cancer," and "chemotherapy medications." The first four search result pages were screened; 69 websites met the inclusion criteria. Two authors performed a quality assessment using the DISCERN instrument. The average scores on the DISCERN tool for each website ranged from 22 to 62.5. The websites were categorized as excellent, good, fair, poor, or very poor. The results showed that 37% of the websites were rated as fair, 27.5% as good, 24.6% as poor, and 10.1% as very poor. Two-thirds of all included websites rated as either fair or good, whereas the remaining websites were rated as poor or very poor, with no websites having excellent ratings. We recommend that website owners and health experts, especially pharmacists, cooperate to deliver reliable health-related information.
Indexed as
Identifiers
40742700What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.